Control of the systolic blood pressure and related factors in patients with high cardiovascular risk

• Published in: Anales de medicina interna (Madrid, Spain : 1984) Vol. 23; no. 3; pp. 119 - 123
• Main Authors: Sánchez Muñoz-Torrero, J F, Crespo Rincón, L, Chiquero Palomo, M, Doncel Rancel, C, Bacaicoa López de Sabando, A, Costo Campoamor, A
• Format: Journal Article
• Language: Spanish
• Published: Spain 01-03-2006
• Subjects: Aged; Antihypertensive Agents - classification; Antihypertensive Agents - therapeutic use; Cardiovascular Diseases - epidemiology; Cohort Studies; Comorbidity; Cross-Sectional Studies; Diabetes Complications - epidemiology; Female; Humans; Hyperlipidemias - epidemiology; Hypertension - drug therapy; Hypertension - epidemiology; Male; Middle Aged; Prospective Studies; Registries; Risk Factors; Spain - epidemiology; Systole - drug effects; Treatment Outcome; Spain
• ISSN: 0212-7199

To know in a good therapeutic compliance population with high cardiovascular risk (HCR), the systolic blood pressure (SBP) control-rate and the factors that could influence.
A cross-sectional observational study was carried out in a HCR hypertensive population in Cáceres (Spain). A survey of different laboratory tests, SBP in first and last visits.
Among 388 HCR hypertensive patients, 199 (51.4%) patients with antihypertensive treatment adherence was selected. The average age was of 63 +/- 11 years, 109 (54.1%) males, 61 (30.7%) diabetes mellitus (DM) ones, the 10 years global cardiovascular risk was 22.25 +/- 8.9%, average follow-up was 16.5 +/- 8 months, means SBP was 158 +/- 22 mm Hg. 59.5% with combined treatment, generally diurets with another antihypertensive one. SBP less 140 mm Hg was observe in 23.9% and, only 13.5% less than 130 mm Hg in DM patients. SBP control was more common in less than five years hypertension diagnosis (with respect to those of more time evolution (33.8% vs 15.7%: p < 0.01). as well as, in those with beat pressure (BP) less of 60 mmHg (73.3% versus 26.7%; p < 0.0005). In multivariable analysis also influences negatively in the SBP control: upper 5 years hypertension diagnosis, OR 1.92 (1.08-3.4; p < 0.05) and, a greater BP of 60 mmHg, OR 30.3 (10.6-87: p < 0.0001).
SBP control is difficult to obtain in a population of HCR and good therapeutic compliance, but more still in DM patients. A time of more 5 years evolution of the hypertension and, BP upper of 60 mm HG, have a negative influences in the SBP control.